Sign in and upgrade to a paid plan to export announcements as CSV.

Shree Ganesh Remedies Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SGRL BSE: 540737
₹687.15
▲ 21.40 (3.21%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
54/100
Moderate
Valuation
6/100
Expensive
Momentum
58/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹882 Cr
PE (TTM)
57.2
Industry median 36.1 (152 companies)
Price to Book
5.4
PEG (TTM)
-1.9
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹7 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-67.66%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-29.46%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-8.76%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-67.53%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-41.79%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
3.96
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.19
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
8.12
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
7.80%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
12.88%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
24.14%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
8.56%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
14.82%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
10.90%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.19)
  • No Return on equity is 15% or more (10.9%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 2 met
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.2%
Low 665.8500 · High 704.0000
1W return
-6.6%
Low 636.8000 · High 739.4500
1M return
13.3%
Low 610.4500 · High 749.8500
52W return
Data unavailable.
Low 477.0500 · High 749.8500
Lifetime High ₹735.5500 (Sept. 23, 2026)
Lifetime Low ₹501.0500 (Aug. 20, 2026)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish0
5D
682.2
10D
681.9
20D
658.9

Delivery and volume

Day avg. delivery
60.4%
Week avg. delivery
59.8%
Month avg. delivery
59.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

685.67
Pivot
First resistance705.48
Second resistance723.82
Third resistance743.63
First support667.33
Second support647.52
Third support629.18
Day RSI58.0
Day MFI45.6
Day MACD—
Day MACD signal—

Beta

1M2.81
3M1.85
1Y1.85
3Y1.85

Price change analysis

↑ 13.3%
Over 1 Month
LowHigh
610.45749.85
—
Over 3 Months
LowHigh
477.05749.85
—
Over 6 Months
LowHigh
477.05749.85
—
Over 1 Year
LowHigh
477.05749.85
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹14 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹0.8700

Ranks #92 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter72.84%
  • Other DII0.52%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 72.84% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
16 Feb 2021 NILESH MANSUKHBHAI PATEL Bulk Sell 78,973 218.7000 BSE
9 Nov 2020 MADRAS PARAMESWARAN MANOJ MAHADEV Bulk Buy 83,650 140.4600 BSE
7 Oct 2019 KHYANI HARSHIL Bulk Buy 51,000 68.7500 BSE
7 Oct 2019 NNM SECURITIES PVT LTD Bulk Sell 51,000 68.7500 BSE
27 Mar 2019 NNM SECURITIES PVT LTD Bulk Buy 3,000 58.0000 BSE
27 Mar 2019 GIRRAJ KISHOR AGARWAL (HUF) Bulk Buy 78,000 68.9200 BSE
27 Mar 2019 NNM SECURITIES PVT LTD Bulk Sell 81,000 68.6500 BSE
6 Feb 2019 MIKER FINANCIAL CONSULTANTS PRIVATE LIMITED Bulk Buy 45,000 51.1000 BSE
15 Jan 2019 RIKHAV SECURITIES LIMITED Bulk Sell 45,000 51.2000 BSE
31 Dec 2018 NNM SECURITIES PVT LTD Bulk Sell 3,000 53.5000 BSE

All bulk and block deals →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Company Update Shree Ganesh Remedies Ltd - 540737 - Appointment of Company Secretary and Compliance Officer
3 Oct 2026 Company Update Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
3 Oct 2026 Others Shree Ganesh Remedies Ltd - 540737 - Board Meeting Outcome for Outcome Of Board Meeting
12 Sep 2026 AGM/EGM Shree Ganesh Remedies Ltd - 540737 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
12 Sep 2026 AGM/EGM Shree Ganesh Remedies Ltd - 540737 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.19)

Weaknesses

  • Declining revenue YoY (-41.8%)
  • Declining profit YoY (-67.5%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (57.2) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Shree Ganesh Remedies Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.